Current Size: 100%
BioGaia Newsletter October 2010
 |
|
| Newsletter Oct 2010 |
 |
|
 BioGaia at Neonatology Congress in CubaBioGaia will host a satellite symposium on Thursday November 11 at the Ibero-American Congress in Neonatology (SIBEN) in Havana, Cuba. The title is “Probióticos en el recién nacido: Evidencia, ficción y futuro”. Dr Teresa del Moral from Miller School of Medicine, University of Miami will chair the symposium. Dr Patricia Mena from Pontifica Catholic University of Chile and Dr José Saavedra from Johns Hopkins University School of Medicine are on the speaker list.
 Cooperation with Swedish SCABioGaia and SCA have signed a long-term collaboration agreement with the aim of developing new health-targeted products through BioGaia´s probiotic bacteria and application technologies combined with SCA´s competence in the field of hygiene products. The objective is to develop products specifically suited to BioGaia´s and SCA´s distribution networks. "It is extremely exciting to see what this collaboration can give since both partners can contribute with both know-how and patented technologies and their own distribution networks. We are highly impressed with SCA´s ambitions in the hygiene area and our hope is that we shall be able to develop new products that can be sold in relatively large volumes through SCA´s distribution net as well as more specialised products for our own distributors." says Peter Rothschild, President BioGaia.  Less crying with ReuteriLactobacillus reuteri Protectis reduced crying time in infants with colic in a new double-blind, randomised placebo-controlled clinical trial. After only one week of supplementation the reduction in daily crying time was 74 % among the infants supplemented by L. reuteri Protectis compared to 38 % in the placebo group. At the end of the study there was a significant difference between the two groups. “These results are in line with previous studies on colic and confirm the benefit of L. reuteri Protectis in colicky infants”, says Doctor F. Savino, Department of Paediatrics, Regina Margherita Children's Hospital, Turin, Italy. Reuteri effective in constipation
Constipated infants supplemented with Lactobacillus reuteri Protectis had a significantly higher frequency of bowel movements compared to the placebo group. Stool consistency improved significantly in the L. reuteri Protectis group during the study, although no significant difference was seen compared to placebo. “This is the first study to show that L. reuteri has positive effects on infants suffering from chronic constipation”, says Professor Annamaria Staiano, Department of Pediatrics, University Federico II, Naples, Italy.
|